Medication info
Cozaar XQ Tablets 5/100 milligrams

Cozaar XQ Tablets 5/100 milligrams

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›100mg / 1 tabletAmlodipine Camsylate›7.84mg / 1 tablet
Manufacturer / importer
Korea Organon Co., Ltd.
Appearance
Pale pink, rectangular film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200908186 · Approved 2009.11.20 · Insurance code 073100010

Summary

Main use
Treatment of hypertension (inadequately controlled with monotherapy; initial therapy for stage 2 hypertension)
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose of each individual component (amlodipine or losartan) be adjusted before starting this medicine. However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50milligrams once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: For patients 75 years of age and older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.
Child dose
∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, use of this medicine is not recommended.

Ingredients

Manufacturer
Korea Organon Co., Ltd.

Efficacy & effects

Treatment of hypertension (inadequately controlled with monotherapy; initial therapy for stage 2 hypertension)

  • Essential hypertension
  • stage 2 hypertension
View approved original text

This medicine is used to effectively control blood pressure in patients with essential hypertension who do not achieve adequate blood pressure control with amlodipine or losartan alone. It also aids stage 2 hypertension patients in reaching their target blood pressure during initial treatment when using combination therapy. This medication is effective for hypertension treatment and contributes to patient blood pressure management and prevention of complications.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. It is recommended that the dose of each individual component (amlodipine or losartan) be adjusted before starting this medicine. However, a direct switch to this medicine may be considered when blood pressure is not adequately controlled with monotherapy using the individual components, as follows: - 5/50 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 50 milligrams as monotherapy. - 5/100 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or losartan 100 milligrams as monotherapy. Patients taking amlodipine and losartan concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Before administering this medicine as initial therapy to patients with stage 2 hypertension, the decision to treat should take into account baseline blood pressure, target blood pressure, and the expected likelihood of achieving the treatment target with the combination product compared with monotherapy. The usual dose is 5/50 milligrams once daily. If blood pressure is not adequately controlled after 2 weeks of treatment, the dose may be increased to 10/50milligrams once daily. ∘ Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (e.g., creatinine clearance 20∼50 mL/min), but use of this medicine is not recommended in patients with moderate to severe renal impairment (e.g., creatinine clearance < 20 mL/min) or in patients on dialysis. ∘ Patients with reduced intravascular effective blood volume: Use of this medicine is not recommended in a small number of patients with reduced intravascular effective blood volume (e.g., patients receiving high-dose diuretics). (See section 1, Warnings, under Precautions for Use.) ∘ Patients with hepatic impairment: Use of this medicine is not recommended for patients with a history of hepatic impairment who require a reduced dose of losartan (e.g., 25 milligrams once daily). ∘ Elderly patients: For patients 75 years of age and older, an initial dose of losartan of 25 milligrams once daily is recommended; therefore, use of this medicine as initial therapy is not recommended.

Child dose

∘ Children: The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, use of this medicine is not recommended.

Precautions

This medication can cause serious harm to the fetus and newborn during pregnancy, and must be discontinued immediately upon confirmation of pregnancy. When initially administered to patients with reduced blood volume, hypotensive symptoms may occur, and it is advisable not to administer this drug to such patients. Individuals allergic to this drug or similar medications should not take it. It should be avoided in patients with severe liver dysfunction, severe aortic stenosis, or in shock. Diabetic patients or those with severe renal impairment should avoid taking this medication with certain other drugs. Due to the blood pressure-lowering effect, dizziness may occur, so caution should be exercised when driving or operating dangerous machinery. This medication may interact strongly when used with other antihypertensive drugs, so it should be taken carefully under medical supervision. Routine checks of blood pressure, renal function, electrolyte levels, etc., should be conducted during treatment to detect any abnormalities. This drug can cause hyperkalemia, so extreme caution is necessary when used with potassium supplements or medications high in potassium. Breastfeeding women are advised not to take this medication, and its safety and efficacy have not been established in children under 18 years of age, thus it is not recommended. In cases of overdose, severe hypotension and heart-related issues may occur, so immediate medical attention is required for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to other containers.

Side effects

  • Dizziness
  • headache
  • drowsiness
  • cerebral infarction
  • weakness
  • chest discomfort
  • chest pain
  • early satiety
  • peripheral edema
  • pitting edema
Show 232 more
  • abdominal discomfort
  • dyspepsia
  • nausea
  • gastroesophageal reflux disease
  • constipation
  • pruritus
  • urticaria
  • palpitations
  • flushing
  • orthostatic hypotension
  • facial flushing
  • dyspnea
  • cough
  • dizziness (vertigo)
  • conjunctival injection
  • frequent urination
  • arthralgia
  • sleep apnea syndrome
  • uterine fibroids
  • uterine prolapse
  • hyperlipidemia
  • osteoporosis
  • diabetes
  • gastric ulcer
  • hypoglycemia
  • pneumonia
  • cerebral hemorrhage
  • death
  • hypotension
  • chest pain
  • sudden death
  • myocardial infarction
  • angina pectoris
  • sepsis
  • gastric carcinoma
  • postural edema
  • tremor
  • nausea
  • herpes zoster
  • hypercholesterolemia
  • unspecified lipid metabolism disorder
  • atherosclerosis
  • pulmonary edema
  • periodontal destruction
  • benign gastrointestinal neoplasm
  • cholelithiasis
  • cholangitis
  • liver cirrhosis
  • fracture
  • ligament disorder
  • albuminuria
  • chronic kidney failure
  • exacerbation of chronic kidney failure
  • renal papillary necrosis
  • prostatic hyperplasia
  • ovarian cyst
  • cataract
  • altered temperature sensation
  • fatigue
  • edema
  • vertigo
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • weight gain/loss
  • hypotension
  • vasculitis
  • tension hypertension
  • sensory decrease
  • sensory abnormalities
  • peripheral neuropathy
  • syncope
  • taste abnormalities
  • tremor
  • erectile dysfunction
  • gynecomastia
  • change in bowel habits
  • dry mouth
  • gastritis
  • gingival hypertrophy
  • pancreatitis
  • vomiting
  • hyperglycemia
  • arthralgia
  • low back pain
  • muscle cramps
  • myalgia
  • leukopenia
  • thrombocytopenia
  • insomnia
  • mood changes
  • cough
  • rhinitis
  • hair loss
  • increased sweating
  • purpura
  • skin discoloration
  • toxic epidermal necrolysis
  • tinnitus
  • visual disturbances
  • increased urinary frequency
  • urinary disorders
  • nocturia
  • hepatitis
  • jaundice
  • elevated liver enzymes
  • skin flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • retrosternal pain
  • diarrhea
  • loose stools
  • constipation
  • skin flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • impaired glucose tolerance
  • weakness
  • muscle cramps
  • low back pain
  • leg pain
  • congestion
  • upper respiratory tract infection
  • sinusitis
  • sinus dysfunction
  • pharyngitis
  • myalgia
  • insomnia
  • edema
  • abdominal pain
  • vascular edema
  • skin peeling phenomenon
  • hemolysis
  • facial edema
  • fever
  • orthostatic effect
  • angina pectoris
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • toothache
  • flatulence
  • gastritis
  • anemia
  • gout
  • upper limb pain
  • hip pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscular rigidity
  • arthritis
  • fibromyalgia
  • myasthenia
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • nervous hyperesthesia
  • panic disorder
  • sleep disorder
  • tremor
  • dizziness
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • dermatitis
  • dry skin
  • petechial hemorrhage
  • erythema
  • photosensitivity
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation and pain in the eyes
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • decreased vision
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactic reaction
  • liver function abnormality
  • lethargy
  • thrombocytopenia
  • rhabdomyolysis
  • taste abnormalities
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • elevated serum creatinine
  • elevated liver enzymes
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • anaphylactoid syndrome
  • excessive peripheral vasodilation
  • reflex tachycardia
  • systemic hypotension
  • shock state
  • shock
  • non-cardiogenic pulmonary edema
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best to maintain a storage temperature between 1 degree and 30 degrees Celsius. Storing it this way will ensure the medication's effectiveness is safely maintained.

Appearance and packaging

Appearance

Pale pink, rectangular film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.